HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku-DNA interaction.

Abstract
DNA-dependent protein kinase (DNA-PK) plays a critical role in the non-homologous end joining (NHEJ) repair pathway and the DNA damage response (DDR). DNA-PK has therefore been pursued for the development of anti-cancer therapeutics in combination with ionizing radiation (IR). We report the discovery of a new class of DNA-PK inhibitors that act via a novel mechanism of action, inhibition of the Ku-DNA interaction. We have developed a series of highly potent and specific Ku-DNA binding inhibitors (Ku-DBi's) that block the Ku-DNA interaction and inhibit DNA-PK kinase activity. Ku-DBi's directly interact with the Ku and inhibit in vitro NHEJ, cellular NHEJ, and potentiate the cellular activity of radiomimetic agents and IR. Analysis of Ku-null cells demonstrates that Ku-DBi's cellular activity is a direct result of Ku inhibition, as Ku-null cells are insensitive to Ku-DBi's. The utility of Ku-DBi's was also revealed in a CRISPR gene-editing model where we demonstrate that the efficiency of gene insertion events was increased in cells pre-treated with Ku-DBi's, consistent with inhibition of NHEJ and activation of homologous recombination to facilitate gene insertion. These data demonstrate the discovery and application of new series of compounds that modulate DNA repair pathways via a unique mechanism of action.
AuthorsNavnath S Gavande, Pamela S VanderVere-Carozza, Katherine S Pawelczak, Pamela Mendoza-Munoz, Tyler L Vernon, Leslyn A Hanakahi, Matthew Summerlin, Joseph R Dynlacht, Annabelle H Farmer, Catherine R Sears, Nawar Al Nasrallah, Joy Garrett, John J Turchi
JournalNucleic acids research (Nucleic Acids Res) Vol. 48 Issue 20 Pg. 11536-11550 (11 18 2020) ISSN: 1362-4962 [Electronic] England
PMID33119767 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
Chemical References
  • Protein Kinase Inhibitors
  • DNA
  • DNA-Activated Protein Kinase
  • Ku Autoantigen
Topics
  • Animals
  • Cells, Cultured
  • DNA (chemistry)
  • DNA Breaks, Double-Stranded
  • DNA End-Joining Repair (drug effects)
  • DNA-Activated Protein Kinase (antagonists & inhibitors)
  • Gene Editing
  • Humans
  • Ku Autoantigen (antagonists & inhibitors, chemistry)
  • Mice
  • Protein Kinase Inhibitors (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: